Automated Benchtop Pipette
The Concentrating Pipette Select from InnovaPrep is a small automated benchtop instrument that can concentrate contaminates from large volumes of liquids for improved detection.
The Concentrating Pipette Select from InnovaPrep is a small automated benchtop instrument that can concentrate contaminates from large volumes of liquids for improved detection. The instrument allows for contamination screening of liquid samples up to 5L and lets users choose from six versions of interchangeable, high-flow filtered pipette tips that feature different specifications to concentrate proteins, viruses, DNA, bacteria, whole cells, fungal spores, or other particles. Recovered particles are delivered in seconds and ready for analysis using user method of choice, according to the company.
Applications for the pipette include biological and particulate contamination monitoring in the environment, as well as monitoring the integrity of various ingredients including water, intermediate products such as cell culture media, and finished products including parenteral fluids and compounded drugs.
According to InnovaPrep, when used as a front-end to rapid molecular methods for quality assurance/quality control monitoring, the instrument allows for sample-to-answer within a single shift, improving detection of trace contamination.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
